Cargando…

ELABELA/APJ Axis Prevents Diabetic Glomerular Endothelial Injury by Regulating AMPK/NLRP3 Pathway

ELABELA (ELA), a recently discovered peptide, is highly expressed in adult kidneys and the endothelium system. It has been identified as a novel endogenous ligand for the apelin receptor (APJ). This study aims to investigate the role of ELA in diabetic glomerular endothelial pyroptosis and its under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhida, Wang, Zhe, Hu, Yepeng, Lin, Huangbo, Yin, Li, Kong, Jing, Zhang, Yikai, Hu, Bibi, Li, Tiekun, Zheng, Xianan, Yang, Qiongying, Ye, Shu, Wang, Shengyao, Zhou, Qiao, Zheng, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673989/ https://www.ncbi.nlm.nih.gov/pubmed/37540330 http://dx.doi.org/10.1007/s10753-023-01882-7

Ejemplares similares

The Elabela-APJ axis: a promising therapeutic target for heart failure
por: Ma, Zheng, et al.
Publicado: (2020)

Sappanone a prevents diabetic kidney disease by inhibiting kidney inflammation and fibrosis via the NF-κB signaling pathway
por: Wang, Zhe, et al.
Publicado: (2022)

Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system
por: Liu, Wei, et al.
Publicado: (2020)

ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway
por: Chen, Zhida, et al.
Publicado: (2020)

Apelin, APJ, and ELABELA: Role in Placental Function, Pregnancy, and Foetal Development—An Overview
por: Dawid, Monika, et al.
Publicado: (2021)

Tubular Elabela-APJ axis attenuates ischemia-reperfusion induced acute kidney injury and the following AKI-CKD transition by protecting renal microcirculation
por: Xiong, Mingrui, et al.
Publicado: (2023)

The Apelinergic System: Apelin, ELABELA, and APJ Action on Cell Apoptosis: Anti-Apoptotic or Pro-Apoptotic Effect?
por: Respekta, Natalia, et al.
Publicado: (2022)

Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway
por: Zhang, Kang-long, et al.
Publicado: (2023)

Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension
por: Yang, Peiran, et al.
Publicado: (2017)

Apelin/APJ axis improves angiotensin II-induced endothelial cell senescence through AMPK/SIRT1 signaling pathway
por: Yang, Rongfeng, et al.
Publicado: (2017)

MicroRNA-122-5p Aggravates Angiotensin II-Mediated Myocardial Fibrosis and Dysfunction in Hypertensive Rats by Regulating the Elabela/Apelin-APJ and ACE2-GDF15-Porimin Signaling
por: Song, Jiawei, et al.
Publicado: (2022)

The Role of Apelin–APJ System in Diabetes and Obesity
por: Li, Cheng, et al.
Publicado: (2022)

The Apelin/APJ System in Psychosis and Neuropathy
por: Lv, Shuang-Yu, et al.
Publicado: (2020)

Apelin-13/APJ system attenuates early brain injury via suppression of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation and oxidative stress in a AMPK-dependent manner after subarachnoid hemorrhage in rats
por: Xu, Weilin, et al.
Publicado: (2019)

Elabela-Apelin Receptor Signaling Pathway is Functional in Mammalian Systems
por: Wang, Zhi, et al.
Publicado: (2015)

Peptide hormone ELABELA enhances extravillous trophoblast differentiation, but placenta is not the major source of circulating ELABELA in pregnancy
por: Georgiadou, Danai, et al.
Publicado: (2019)

Elabela gene therapy promotes angiogenesis after myocardial infarction
por: Jin, Liangli, et al.
Publicado: (2021)

Apelin/APJ relieve diabetic cardiomyopathy by reducing microvascular dysfunction
por: Li, Bin, et al.
Publicado: (2021)

The Role of the Apelin/APJ System in the Regulation of Liver Disease
por: Lv, Xinrui, et al.
Publicado: (2017)

Apelin/APJ-Manipulated CaMKK/AMPK/GSK3β Signaling Works as an Endogenous Counterinjury Mechanism in Promoting the Vitality of Random-Pattern Skin Flaps
por: Lou, Zhi-Ling, et al.
Publicado: (2021)

The Apelin-APJ System in the Evolution of Heart Failure
por: GOIDESCU, CERASELA MIHAELA, et al.
Publicado: (2015)

Expanding role for the apelin/APJ system in physiopathology
por: Carpéné, C., et al.
Publicado: (2007)

Apelin/APJ system: an emerging therapeutic target for neurological diseases
por: Li, Ao, et al.
Publicado: (2022)

Sexual Dimorphism in the Polarization of Cardiac ILCs through Elabela
por: Salles, Évila Lopes, et al.
Publicado: (2022)

APJ ACTS AS A DUAL RECEPTOR IN CARDIAC HYPERTROPHY
por: Scimia, Maria Cecilia, et al.
Publicado: (2012)

Elabela: Negative Regulation of Ferroptosis in Trophoblasts via the Ferritinophagy Pathway Implicated in the Pathogenesis of Preeclampsia
por: Yang, Huan, et al.
Publicado: (2022)

Advances in the study of ELABELA in renal physiological functions and related diseases
por: Liu, YuRong, et al.
Publicado: (2023)

Interaction of apelin, elabela and nitric oxide in schizophrenia patients
por: Catak, Zekiye, et al.
Publicado: (2020)

Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension
por: Song, Jiawei, et al.
Publicado: (2022)

Predicting late‐onset preeclampsia by detecting ELABELA content using an immunochromatographic colloidal gold test strip: Blood ELABELA content predicts the risk of pre‐eclampsia
por: Yang, Na, et al.
Publicado: (2023)

The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles
por: Jiang, Yunlu, et al.
Publicado: (2021)

The Role of Apelin/APJ in a Mouse Model of Oxygen-induced Retinopathy
por: Feng, Jing, et al.
Publicado: (2020)

A promoter polymorphism in APJ gene is significantly associated with blood pressure changes and hypertension risk in Chinese women
por: Li, Guofeng, et al.
Publicado: (2016)

Apelin/APJ system: A key therapeutic target for liver disease
por: Lv, Shuang-Yu, et al.
Publicado: (2017)

Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer
por: Liu, Longfei, et al.
Publicado: (2021)

The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis
por: Helker, Christian SM, et al.
Publicado: (2015)

Uma Nova Via para Oclusão Coronariana com Elabela?
Publicado: (2021)

ELABELA acts as a protective biomarker in patients with atrial fibrillation
por: Cui, Chunhong, et al.
Publicado: (2021)

Elabela and Apelin regulate coronary angiogenesis in a competitive manner
por: A. Madiha, Syeda, et al.
Publicado: (2023)

AMPK mediates regulation of glomerular volume and podocyte survival
por: Banu, Khadija, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2h2e9o988d10s82l6shqlrcmkl